ArticleRadiology case reports2026
Isolated pulmonary lymphangitic carcinomatosis as the initial manifestation of renal cell carcinoma.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary lymphangitic carcinomatosis (PLC) is a rare manifestation of metastatic disease caused by infiltration of malignant cells within pulmonary lymphatic vessels, most commonly from breast, lung, gastric, or pancreatic cancers. Lymphangitic spread from renal cell carcinoma (RCC) is exceedingly uncommon, especially when occurring without pulmonary nodules, masses, or mediastinal lymphadenopathy. We report a 68-year-old man with extensive vascular disease and a significant smoking history who presented with progressive cough and unilateral pulmonary opacities. His symptoms worsened over six weeks despite antibiotic and corticosteroid therapy. Imaging demonstrated diffuse interlobular septal and peribronchovascular thickening with recurrent pleural effusions. Initial thoracenteses revealed exudative effusions with negative cytology. Subsequent bone marrow biopsy and bronchoscopic cryobiopsy confirmed poorly differentiated carcinoma with lymphovascular invasion consistent with RCC. Positron emission tomography revealed pulmonary, pleural, and osseous metastases. Despite initiation of immune checkpoint inhibitor therapy, the patient experienced rapid respiratory decline and transitioned to comfort-focused care. This case underscores a rare presentation of RCC as isolated PLC without nodules or mediastinal lymphadenopathy. Recognition of characteristic imaging patterns and timely tissue diagnosis are essential for accurate diagnosis, prognostication, and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.